Foam respiratory mask

- ResMed Pty Ltd

A patient interface for delivering breathable gas to a patient includes a foam interfacing portion adapted to provide a nasal interface to contact under and around the patient's nose in use and including an orifice adapted to surround both the patient's nares in use, and a positioning and stabilizing structure to support the foam interfacing portion in an operative position on the patient's face. The positioning and stabilizing structure is structured to provide a range of rotational, axial, and/or lateral movement to the foam interfacing portion while maintaining a sufficient interface and resisting the application of tube drag and/or headgear tension to the foam interfacing portion.

Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description
CROSS-REFERENCE TO RELATED APPLICATION

    • This application is a continuation of U.S. patent application Ser. No. 12/735,977, filed Aug. 27, 2010, which was the U.S. national phase of International Application No. PCT/AU2009/000240, filed Feb. 27, 2009, which designated the U.S. and claims the benefit of Australian Provisional Application No. AU 2008901057, filed Mar. 4, 2008, each of which is hereby incorporated herein by reference in its entirety.

FIELD OF THE INVENTION

The present invention relates to a respiratory mask used for treatment, e.g., of Sleep Disordered Breathing (SDB) with Continuous Positive Airway Pressure (CPAP) or Non-Invasive Positive Pressure Ventilation (NIPPY). In particular, the present invention relates to a respiratory mask with a foam contacting portion. Also, the present invention relates to a respiratory mask that is comfortable, easy to use and requires little maintenance.

BACKGROUND OF THE INVENTION

Typically, respiratory therapy is delivered in the form of a respiratory mask or mask system positioned between a patient and apparatus providing a supply of pressurized air or breathing gas. Mask systems in the field of the invention differ from mask systems used in other applications such as aviation and safety in particular because of their emphasis on comfort. This high level of comfort is desired because patients must sleep wearing the masks for hours, possibly every night for the rest of their lives. In addition, therapy compliance can be improved if the patient's bed partner is not adversely affected by the patient's therapy and wearing of the mask generally.

Mask systems typically have a highly clinical aesthetic (as will be described below). This may lead to patients becoming embarrassed about their therapy since the clinical aesthetic serves as a blatant reminder that they are ill and consequently can leave a negative perception of the patient in the mind of an observer.

Mask systems typically, although not always, comprise (i) a rigid or semi-rigid portion often referred to as a shell or frame, (ii) a soft, patient contacting portion often referred to as a cushion, and (iii) some form of headgear to hold the frame and cushion in position. If the mask system does include multiple components, at least some assembly and adjustment may be required, which can be difficult for patients who may suffer from lack of dexterity, etc. Further, mask systems often include a mechanism for connecting an air delivery conduit. The air delivery conduit may preferably be connected to a blower or flow generator.

Patient contacting portions, e.g., cushions, are typically constructed of a silicone material, but patient contacting portions including foam are known. For example, U.S. Pat. No. 5,429,683 (Le Mitouard) discloses a lining for a mask made of a polyurethane foam covered with skin (e.g., latex or silicone). However, skinned foam does not allow the portion in contact with the face to breathe, which can lead to skin irritation, and the sealing portion may be subject to creasing which may cause discomfort and lead to leak. The skin can also feel too hard for some patients, depending on the thickness and support structure. The skin also does not allow a high degree of local deformation and may be subject to tension transfer across its surface, which can result in shifting of the mask on the face and loss of seal/comfort.

A range of mask systems are known including nasal masks, nose & mouth masks, full face masks and nasal prongs, pillows, nozzles & cannulae. Masks typically cover more of the face than nasal prongs, pillows, nozzles and cannulae.

There is a continuous need in the art to provide mask systems with a high level of comfort and usability and a newly perceived need to provide mask systems having improved aesthetics.

SUMMARY OF THE INVENTION

One aspect of the invention is to provide an attachable interfacing portion for a respiratory mask.

Another aspect of the invention is to provide a removably attachable interfacing portion for a respiratory mask.

In an embodiment, the respiratory mask is a nasal mask, and the interfacing portion is a foam contacting portion that is arranged in use between the nose of the patient and the mask system. The foam contacting portion provides a seal between the nares of the patient and the mask system so as to deliver pressurized gas to the patient. The mask system may include a cushion, gusset and/or frame.

In one form, the nasal mask system may be provided with a releasable and replaceable foam contacting portion that it connected to the mask system by at least one connector.

In embodiments, the foam contacting portion may be connected to the mask system (e.g., connected to the frame, decoupling element, and/or headgear) by male and female connectors, a hook and loop arrangement, a press stud arrangement, hook and loop material, a clip arrangement, and/or an adhesive. In another embodiment, the foam contacting portion may be connected or otherwise provided to the mask system using existing structure on the frame, decoupling element, and/or headgear, e.g., without connectors and/or adhesive.

In another form, the nasal mask system may be provided with a removable foam contacting potion that adjoins to the mask system by wrapping about or around the mask system.

In one form, the foam contacting portion may be retrofitted to an existing nasal mask.

In another form, the foam contacting portion includes a foam sleeve that that may be slidingly positioned over a support structure. The foam sleeve may be removably positionable. In one form, the foam sleeve is sock-like.

Another aspect of the invention relates to a patient interface for delivering breathable gas to a patient including a foam interfacing portion adapted to provide a nasal interface to contact under and around the patient's nose in use and including an orifice adapted to surround both the patient's nares in use, and a positioning and stabilizing structure to support the foam interfacing portion in an operative position on the patient's face. The positioning and stabilizing structure is structured to provide a range of rotational, axial, and/or lateral movement to the foam interfacing portion while maintaining a sufficient interface and resisting the application of tube drag and/or headgear tension to the foam interfacing portion.

Other aspects, features, and advantages of this invention will become apparent from the following detailed description when taken in conjunction with the accompanying drawings, which are a part of this disclosure and which illustrate, by way of example, principles of this invention.

BRIEF DESCRIPTION OF THE DRAWINGS

The accompanying drawings facilitate an understanding of the various embodiments of this invention. In such drawings:

FIG. 1 depicts a side view of a nasal mask with a foam contacting portion in use according to an embodiment of the present invention;

FIG. 2 depicts a top view of the nasal mask of FIG. 1;

FIG. 3 depicts a front view of the nasal mask of FIG. 1;

FIGS. 4 and 5 depict isometric views of a nasal mask with a foam contacting portion assembled according to an embodiment of the present invention;

FIG. 6 depicts a side view of the nasal mask of FIGS. 4 and 5;

FIG. 7 depicts a front view of the nasal mask of FIGS. 4 and 5;

FIG. 8 depicts a top view of the nasal mask of FIGS. 4 and 5;

FIG. 9 depicts a rear view of the nasal mask of FIGS. 4 and 5;

FIG. 10 depicts a side view of a foam contacting portion according to an embodiment of the present invention;

FIG. 11 depicts a side view of an unassembled foam contacting portion and mask system according to an embodiment of the present invention;

FIG. 12 depicts a side view of an assembled foam contacting portion and mask system according to an embodiment of the present invention;

FIG. 13 depicts front and rear views of an assembled foam contacting portion and mask system in use according to an embodiment of the present invention;

FIG. 14 depicts a top view of a foam contacting portion with an intermediate connecting structure according to an embodiment of the present invention;

FIGS. 15A, 15B, 15C, and 15D depict top views of foam contacting portions according to embodiments of the present invention;

FIG. 16 depicts an isometric view of a foam contacting portion according to an embodiment of the present invention;

FIG. 17 depicts a rear view of the foam contacting portion of FIG. 16;

FIG. 18 depicts a top view of the foam contacting portion of FIG. 16;

FIGS. 19, 20 and 21 depict various views of a foam contacting portion reconnecting to itself about a mask system according to an embodiment of the present invention;

FIG. 22 depicts a side view of an unassembled foam contacting portion and mask system with a hook and loop connection according to an embodiment of the present invention;

FIGS. 23 and 24 depict a side view of a hook and loop connection in assembly according to an embodiment of the present invention;

FIG. 25 depicts a rear view of a hook and loop connection in assembly according to an embodiment of the present invention;

FIGS. 26, 27 and 28 depict various views of an assembled foam contacting portion and mask system with a hook and loop connection using headgear connectors according to an embodiment of the present invention;

FIGS. 29 and 30 depict a side view of an unassembled foam contacting portion and mask system with a hook and loop connection using a detent according to an embodiment of the present invention;

FIG. 31 depicts a side view of an unassembled foam contacting portion and mask system with a stud connection according to an embodiment of the present invention;

FIG. 32 depicts a front view of an assembled foam contacting portion and mask system with a clipped connection according to an embodiment of the present invention;

FIG. 33 depicts a back view of an assembled foam contacting portion and mask system with a clipped connection according to an embodiment of the present invention;

FIG. 34 depicts a side view of an assembled foam contacting portion and mask system with a clipped connection according to an embodiment of the present invention;

FIG. 35 depicts a top view of an assembled foam contacting portion and mask system with a clipped connection according to an embodiment of the present invention;

FIG. 36 depicts a rear view of an assembled foam contacting portion and mask system with a clipped connection according to an embodiment of the present invention;

FIG. 37 depicts a front view of a foam contacting portion with a clip connection according to an embodiment of the present invention;

FIG. 38 depicts a back view of a foam contacting portion with a clip connection according to an embodiment of the present invention;

FIG. 39 depicts a side view of a foam contacting portion with a clip connection according to an embodiment of the present invention;

FIG. 40 depicts a top view of a foam contacting portion with a clip connection according to an embodiment of the present invention;

FIG. 41 depicts a rear view of a foam contacting portion with a clip connection according to an embodiment of the present invention;

FIGS. 42 and 43 depict the naris region of a patient;

FIG. 44 depicts a top view of a foam contacting portion according to an embodiment of the present invention;

FIG. 45 depicts a side view of the foam contacting portion of FIG. 44;

FIG. 46 depicts a side view of a locking pin according to an embodiment of the present invention;

FIG. 47 depicts a side view of a mask system according to an embodiment of the present invention;

FIG. 48 depicts a side view of a mask system according to an embodiment of the present invention;

FIG. 49 depicts an isometric view of a support structure according to an embodiment of the present invention;

FIG. 50 depicts a bottom view of the support structure of FIG. 49;

FIG. 51 depicts a top view of the support structure of FIG. 49;

FIG. 52 depicts a front view of the support structure of FIG. 49;

FIG. 53 depicts a rear view of the support structure of FIG. 49;

FIG. 54 depicts a side view of the support structure of FIG. 49;

FIG. 55 depicts an isometric view of a mask system according to an embodiment of the present invention;

FIG. 56 depicts a top view of the mask system of FIG. 55;

FIG. 57 depicts a side view of the mask system of FIG. 55;

FIG. 58 depicts a bottom view of the mask system of FIG. 55; and

FIG. 59 depicts a front view of the mask system of FIG. 55.

 DETAILED DESCRIPTION OF ILLUSTRATED EMBODIMENTS

The following description is provided in relation to several embodiments which may share common characteristics and features. It is to be understood that one or more features of any one embodiment may be combinable with one or more features of the other embodiments. In addition, any single feature or combination of features in any of the embodiments may constitute additional embodiments.

In this specification, the word “comprising” is to be understood in its “open” sense, that is, in the sense of “including”, and thus not limited to its “closed” sense, that is the sense of “consisting only of”. A corresponding meaning is to be attributed to the corresponding words “comprise”, “comprised” and “comprises” where they appear.

The term “air” will be taken to include breathable gases, for example air with supplemental oxygen. It is also acknowledged that the positive airway pressure (PAP) devices or flow generators described herein may be designed to pump fluids other than air.

In broad terms, a patient interface in accordance with an embodiment of the invention may comprise three functional aspects: (i) interfacing, (ii) positioning and stabilizing, and (iii) air delivery. These three functional aspects may be constructed from one or more structural components, with a given structural component potentially fulfilling more than one function. For example, a mask frame may serve as part of a positioning and stabilizing function and allow the supply of air.

In an embodiment, as shown in FIGS. 1-3, the patient interface 10 may include a mask system 100, a positioning and stabilizing structure 30, and an air delivery system 130. Mask system 100 may include an interfacing portion 200. Positioning and stabilizing structure 30 may include a frame 110 and/or decoupling element 170 and/or a headgear 50 (that may include top straps 60, a back strap 70, one or more side straps 80 and rigidizers 90). Air delivery system 130 may include: an elbow 140 and a tube 150.

In addition, a patient interface 10 in accordance with an embodiment of the invention may perform other functions including venting of exhaled gases, decoupling of potentially seal disruptive forces and adjustment for different sized faces. Venting may be performed by different structures, e.g., such as the frame 110, the elbow 140 and/or the tube 150.

1. Interfacing

1.1 Introduction

In an embodiment, the interfacing function is provided by a nasal cushion (or “nasal cradle”) that is placed at an entrance to the patient's nares. The nasal cushion is structured to form an interface with the nares and is shaped, oriented, sized and constructed so as provide a fit with a range of differently shaped and located flares.

The nasal cushion may be formed of foam (also referred to as a foam contacting portion). As shown generally in FIGS. 1-3, nasal cushion or foam contacting portion 200 may be positioned at the nares or under the nose. Foam contacting portion 200 may cushion the nares of the patient to increase comfort. Foam contacting portion 200 may also seal with the nares of the patient, e.g., if the foam is a closed cell foam. Alternatively, foam contacting portion 200 may be constructed from an open cell foam or a foam with some open cells, such that it allows a certain degree of leak while delivering sufficient pressure to the patient in the intended therapeutic effect. Instead, such a foam will allow some air to pass through the foam and leak gases into the atmosphere. This may be desirable to assist in venting.

In an embodiment, the foam contacting portion 200 may be maintained in position using stabilizing portions or rigidizers 90 attached to, or formed as part of headgear 50. In this form, the mask system 100 may be generally arranged per ResMed's MIRAGE SWIFT™ nasal pillows and as described in PCT Publication No. WO 2004/073778 (Gunaratnam et al), the contents of which are hereby expressly incorporated by cross-reference.

1.2 Foam

The foam used for the foam contacting portion 200 may be the same as that disclosed in PCT Publication No. WO 2008/070929 (Veliss et al), filed Dec. 14, 2007, which is incorporated herein by reference in its entirety. Alternatively, any suitable foam may be used, for example skinned foam.

In another embodiment, the cushion or foam contacting portion 200 of the mask system 100 may be the cushion disclosed in U.S. patent application Ser. No. 12/219,852 (Guney et al), filed Jan. 11, 2008, which is incorporated herein by reference in its entirety.

The foam contacting portion 200 may be a single piece of foam. In another form, the foam contacting portion 200 may be multiple pieces of foam joined together by any suitable means, for example gluing or insert molding.

As shown in the embodiment of FIGS. 4-9, the foam contacting portion 200 may have an orifice 250 for delivery of pressurized air. In one form, the orifice 250 provided to the foam contacting portion 200 will align with an orifice or aperture 175 or orifices in the decoupling element 170 (e.g., see FIGS. 11 and 12) and/or aperture 115 on frame 110 (e.g., see FIGS. 8 and 9) which is connected to elbow 140 and tube 150, so as to deliver pressurized gas to the patient. The orifice 250 or orifices provided to the foam contacting portion 200 may be the same size, smaller or larger than the aperture 175 and/or aperture 115.

In an embodiment, the thickness of foam contacting portion 200 may be 0.5-50 mm. For example, the thickness of foam contacting portion 200 may be 7-15 mm. In an exemplary embodiment, the thickness of foam contacting portion 200 may be 11 mm.

In an embodiment, the length of foam contacting portion 200 may be 10 mm-200 mm (or its largest length if it is not square). For example, the length of foam contacting portion 200 may be 40-120 min. In an exemplary embodiment, the length of foam contacting portion 200 may be 105 mm. In an embodiment, the width of foam contacting portion 200 may be 10 mm-100 mm (or its largest width if it is not square). For example, the width of foam contacting portion 200 may be 30-70 mm. In an exemplary embodiment, the width of foam contacting portion 200 may be 50 mm.

As disclosed in PCT Publication No. WO 2008/070929 (Veliss et al), the foam contacting portion may be impermeable or air permeable. Air permeability may give the foam interface a unique breathability, which acts to increase the comfort at the interface with the user's nose and skin. All air permeability aspects of PCT Publication No. WO 2008/070929 (Veliss et al) are incorporated herein by reference, and all embodiments in this disclosure may contain foam that is air permeable.

In another embodiment, the foam contacting portion 200 may be retrofitted to existing mask designs, for example ResMed's MIRAGE SWIFT™ as disclosed in U.S. Pat. No. 7,318,437 (Gunaratnam et al) and U.S. Patent Publication No. 2005/0241644 (Lynch et al), each of which is incorporated herein by reference.

1.3 Interface Attachment

Desirable features of an attachment mechanism of the foam contacting portion 200 to the positioning and stabilizing structure may include: satisfactory comfort, effective position of the interfacing portion and/or being easy to use. Due to the softness of foam, hard connecting pieces may in some forms be felt by the patient's face through the foam. Thus, attachment mechanisms that avoid such patient contact may be desired.

In another embodiment, the foam contacting portion 200 may be connected to a positioning and stabilizing structure such as a frame 110 and/or a decoupling element 170 or any other part of the mask system 100 by connecting elements such as hook and loop connectors, press studs, etc. Exemplary connecting elements are described below.

1.3.1 Wrap

In an embodiment, as shown in FIG. 4-13, the foam contacting portion 200 may be connected to a mask system 100 by wrapping the foam over or around the mask system 100. The foam contacting portion 200 may be secured in its wrapped position on the mask system 100 by a male connector 300 and female connector 310 or series of connectors 300, for example see FIGS. 9, 10-11, 13, 16 and 17. In the illustrated embodiment, the male connector 300 is provided to the foam contacting portion 200 and the female connector 310 is provided to the frame 110 and/or decoupling element 170. However, it should be appreciated that the reverse arrangement is possible, i.e., male connector may be provided to the frame and/or decoupling element and the female connector may be provided to the foam contacting portion.

The foam contacting portion 200 may be any shape such as generally rectangular (see FIG. 15A), oval (see FIGS. 15C and 16-18) or hexagonal (see FIG. 15B). Additionally, the foam contacting portion 200 may be any irregular shape, e.g., Y-shaped (see FIG. 15D).

As shown in FIG. 11, the foam contacting portion 200 may have male connectors 300 that engage with opposing female connectors 310 on the mask system 100. The female connectors 310 on the mask system 100 may be on a flexible component (for example, decoupling element 170). Alternatively, the female connectors 310 on the mask system 100 may be on a less flexible component (for example, frame 110).

The male connectors 300 may be fixed to the foam contacting portion 200 by a range of techniques, for example glue. The female connectors 310 may be fixed to the mask system 100 by a range of techniques, for example glue. In another form, the female connectors 310 may be co-molded to the mask system 100. However, the male and female connectors may be permanently or removably attached in other suitable manners.

In a further embodiment, the foam contacting portion 200 may not connect to the mask system 100 by male connectors 300 on the foam contacting portion 200 and female connectors 310 on the mask system 100, e.g., instead the foam contacting portion 200 may reconnect to itself. For example, as shown in FIG. 19-21, the male connectors 300 will be placed at one end of the foam contacting portion 200 with the female connectors 310 at the other end of the foam contacting portion 200, which can then be wrapped around the mask system 100 and connected together at connection points 320.

In another embodiment, the foam contacting portion may include a stretchable foam structured to expand or stretch to fit over the frame, decoupling element, etc., and then return to its original shape to tightly grasp the intended surface.

In a further embodiment, the connection mechanism may be via a hook 330 and loop 340 system, as shown in FIGS. 22-25. The male connectors 300 on the foam contacting portion 200 may take the form of hook 330. The female connectors 310 on the mask system 100 may take the form of loop 340. The loop 340 may be an additional piece attached to the mask system 100 or it may be a hole or aperture in the mask system 100 to allow engagement of the hook 330 (e.g., see FIGS. 23-25).

Alternatively, the reverse arrangement is possible (i.e., loop 340 or hole on the foam contacting portion 200 and hook 330 on the mask system 100). In this form, the loop 340 may be a hole in the foam contacting portion 200, and the hook 330 on the mask system 100 may be an attached or co-molded hook 330 or may be a pre-existing structure on the mask system 100. For example, FIGS. 26-28 illustrate an embodiment in which connectors 350 on the frame 110 (e.g., headgear connecting portions for attaching headgear) extend through respective openings 340 provided to ends of the foam contacting portion. In yet another form, the hook 330 may have a detent 335 to ensure retention of the loop 340, as shown in FIGS. 29-30. The hook 330 and loop 340 may be made from a range of different materials or combination of materials, including but not limited to: wire, silicone, polycarbonate, polypropylene, TPE, polyethylene or any other suitable material.

In a further embodiment, the connection mechanism may be achieved by a press stud 360 as shown in FIG. 31. The male connectors 300 on the foam contacting portion 200 may take the form of a stud 360. The female connectors 310 on the mask system 100 (e.g., frame 110 or decoupling element 170) may take the form of a hole or recess 370. Alternatively, the reverse arrangement is possible (i.e., hole 370 on the foam contacting portion 200 and stud 360 on the mask system 100). The press stud 360 may be made from materials such as metals, polymers or any other suitable material.

In a further embodiment, as shown in FIGS. 44-47, the foam contacting portion 200 may be provided with apertures 380 that are intended to be positioned adjacent alignment holes 180 on the mask system 100. A pin or anchor 390 may be used to secure foam contacting portion 200 onto mask system 100 by inserting the anchor 390 through apertures 380 and alignment holes 180 (see FIG. 47). Anchor 390 may have one or more locking portions 395 so that once in position, the foam contacting portion 200 remains in its position on the mask system 100.

In a further embodiment, the foam contacting portion 200 may be wrapped onto or around the mask system 100 and connected by other type of mechanisms, including but not limited to hook and loop material (e.g., Velcro') or magnets.

In a further embodiment, the wrapped foam contacting portion 200 may be permanently connected to the mask system 100, for example, by gluing, welding or co-molding. For example, the mask system 100 may be made from a foam that can be co-molded with another foam to form the foam contacting portion 200. In yet another embodiment, the foam may be a flocking foam that is provided to (e.g., sprayed onto) the frame, decoupling element, etc.

Exemplary benefits of the wrapped foam contacting portion 200 may include: the ease of sealing the foam contacting portion with the patient and the mask system, continuity of feel, top lip comfort, retro-fitability, intuitiveness of assembly and mass production capability. Other benefits of the wrapped foam may include: if the intention is to replace the foam contacting portion on a regular basis (e.g., daily, weekly or monthly—as disclosed in PCT Publication WO 2008/070929 (Veliss et al)), the portion that is disposed of is small compared to the mask system. This embodiment therefore minimizes waste and maximizes efficiencies around the packaging, storage and transportation of the replacement foam contacting portions.

1.3.2 Clip

In another form, the foam contacting portion 200 may be connected to a mask system 100 by clipping the foam into the mask system 100. The foam contacting portion 200 may be secured in its clipped position on the mask system 100, e.g., by an interference fit.

FIGS. 32-36 show foam contacting portion 200 clipped into the mask system 100 by a clip 400. Clip 400 is slidably engaged with mask system 100 and secures by an interference fit with a portion (e.g., frame 110) of the mask system 100. In an embodiment, clip 400 may be interference fit via locking bumps 410 with step 120 on mask system 100 (see FIG. 48). In an alternative embodiment, clip 400 may be secured in place by another other means, including but not limited to: screw type mechanism. In another alternative embodiment, the clip 400 may be permanently secured to mask system 100, for example, by adhesive. In another alternative embodiment, clip 400 may be co-molded or be continuous with the mask system 100.

The clip 400 may be fixed to the foam contacting portion 200 permanently, for example by adhesive or co-molding. Alternatively, clip 400 may be releasably connected to foam contacting portion 200, including but not limited to: hook and loop material (e.g., Velcro™.

In an embodiment, clip 400 may have a support structure 420 that may have a generally elliptical cross section (e.g., see FIGS. 33, 34, 37-39, and 41). Support structure 420 may engage with mask system 100 to secure the foam contacting portion 200 in place. Support structure 420 may also assist in presenting the foam contacting structure 200 at a desirable orientation to the patient's nose. Support structure 420 may be hollow to allow the flow of pressurized gas from air delivery tube 150 to orifice 250 of foam contacting portion 200.

In an embodiment, clip 400 may comprise an upper surface 440 that engages with foam contacting portion 200 (e.g., see FIGS. 33, 34, 39, and 41). Upper surface 440 may be generally planar. In an exemplary embodiment, upper surface 440 may be curved to conform to the contours of the patient's face to improve comfort and seal of the mask. Upper surface 440 may be as wide as the foam contacting portion 200. Alternatively, upper surface 440 may be smaller or less wide than the foam contacting portion 200 such that the outer edge of foam contacting portion 200 is able to overhang the upper surface 440 and thus flex at its edge. This arrangement may allow the foam contacting portion to better conform to the patient's face.

1.3.3 Other

In a further embodiment, the foam contacting portion 200 need not be connected to the mask system 100 via connecting elements. Rather, the foam contacting portion 200 may be placed on the mask system 100 by other means such as pulled over (e.g., like a sock). For example, as shown in FIGS. 55-59, contacting portion 200 may be a cylindrical or continuous portion of foam with an opening 800 to receive the frame 110 and headgear connecting portions 112. Foam contacting portion 200 may also have orifice 250 for interfacing with aperture 175 in decoupling portion 170 to allow the delivery of breathable gas to the patient. Foam contacting portion 200 may also have opening 260 for interfacing with aperture 115 of frame 110.

In another embodiment, the foam contacting portion 200 may be connected to an intermediate connecting structure 315 (see FIG. 14). This intermediate connecting structure 315 may connect to the foam contacting portion 200 on one side and connect to the mask system 100 on the other side. This may include but is not limited to: the foam contacting portion 200 may be connected to a piece of flexible fabric material (e.g., Breath-O-Prene™ by Accumed) which is then connected to the mask system 100 (or part(s) of the mask system 100). Alternatively, the intermediate connecting structure 315 shown in FIG. 14 may not connect to the mask system 100, instead it may wrap around the mask system and the left and right intermediate connecting structures 315 may connect to each other.

In a further embodiment, the foam may be fixed (e.g., using an adhesive) to an adaptor or clipping mechanism, which in turn connects via an interference fit onto the mask frame.

1.4 Interface Size

In a further embodiment, the foam may be provided in various sizes to accommodate varying anthropometric requirements. Typical nasal pillow designs have sizes based on the nostrils of the population as these pillows seal around the nares. However, the same sizing may not be ideal for the foam contacting portion 200 as it does not seal on the edge of, or inside the nares. Instead sizing may be based on sealing against the area around the nares (as indicated by the dashed line d1 around the nares in FIG. 42).

FIG. 42 presents a two-dimensional view of the underside of the nose and defines the areas that may be considered for sealing the nostrils. The orifice 250 on the foam contacting portion 200 should be within the bounds of the area of the nose (shown by the dashed line d2 in FIG. 42) so that the mask can sealingly engage with the nose. Should the orifice 250 be any larger than the region of the nose (dashed line d2), the mask may leak. In an embodiment, the orifice 250 should not be any smaller than the region within the nares (shown by the dashed line d1) so as to occlude the patient's airway. The orifice in the foam may encroach on the nostril openings on some noses and some degree of partial occlusion may be acceptable.

In a further embodiment, there may be one orifice 250 in the foam contacting portion 200. In one form, the orifice 250 in the foam contacting portion 200 may be generally trapezoidal or ‘D’ shaped as shown in FIGS. 8, and 16-18. In another form, the orifice 250 may be circular or oval (as shown in FIGS. 14 and 15A-15D), square (not shown) or any other shape fitting within the aforementioned limits.

In a further embodiment and referring to FIG. 43, the orifice 250 in the foam contacting portion 200 may be 15-50 mm wide (indicated in FIG. 43 by dimension 500). In an exemplary embodiment, the orifice 250 in the foam contacting portion 200 may be about 22 mm wide. In another exemplary embodiment, the orifice 250 in the foam contacting portion 200 may be about 31 mm wide. In an embodiment, the orifice 250 in the foam contacting portion 200 may be 5-30 mm high (indicated in FIG. 43 by dimension 600). In an exemplary embodiment, the orifice 250 in the foam contacting portion 200 may be about 11 mm high. In another exemplary embodiment, the orifice 250 in the foam contacting portion 200 may be about 16 mm high.

In a further embodiment, the orifice 250 in the foam contacting portion 200 may have an angle of 10-80° (indicated in FIG. 43 by dimension 700). In an exemplary embodiment, angle 700 is about 67°. In another exemplary embodiment, angle 700 is about 50°.

In a further embodiment, there may be more than one orifice 250 in the foam contacting portion 200. In one form, there may be two orifices 250, e.g., each generally oval in shape. In another form, there may be a plurality of orifices 250 (for example, 3, 4, 5, 10 or more), e.g., each that are generally round. In another form, there may be multiple orifices 250 of any shape, within the limits shown above (indicated by the dashed lines d1 and d2 in FIG. 42).

2. Positioning and Stabilizing Structure

2.1 Introduction

A patient interface 10 provides a structure for suitable positioning, suspension and stabilizing of the interfacing portion 200 of the patient interface 10 at an entrance to the airways of the patient. This structure includes: the decoupling element 170, the frame 110 and headgear 50 with rigidizers 90. The decoupling element 170 acts as a form of suspension system or force insulation system whereby it isolates forces from one portion of the patient interface 10 from another portion of the patient interface 10. The headgear 50 and rigidizers 90 form a structure that may resist bending in one or more directions (and/or from tube drag) and yet is flexible to conform to different facial geometries, or to move in response to other potentially disruptive forces. In combination with the suspension system, a greater range of movement of a mask system in accordance with an embodiment of the invention can be accommodated without disrupting the seal than in prior art mask systems.

2.2 Frame

A frame 110 in accordance with an embodiment of the present invention as shown in FIGS. 49-54, serves a number of functions, including: a connection point to decoupling element 170, headgear rigidizers 90 and elbow 140. A given functional feature may reside in different structures. For example, the stabilizing portion of headgear 50 may be formed as part of a frame 110 either additionally or alternatively.

Frame 110 may connect to the elbow 140 via aperture 115, whereby the elbow clips into the aperture 115, or interfaces with the aperture 115 by any such means so as to join the elbow 140 to the frame 110. Frame 110 may be generally rectangular or any other desired shape, for example see FIGS. 49-54. Frame 110 is intended to support the decoupling element 170 and foam contacting portion 200 and connect the mask system 100 to the headgear 50, thereby securing the mask system 100 on the patient's face. Frame 110 connects to the headgear 50 by connecting portions 112, where rigidizers 90 removably connect to connecting portions 112 (e.g., see FIG. 7). Such a connection is described in U.S. patent application Ser. No. 12/219,852 (Guney), which is incorporated herein by reference in its entirety. Frame 110 may be at least partially constructed from a resilient material such as silicone, polycarbonate, polypropylene, nylon, or any other desired material.

2.3 Decoupling Element

Decoupling element 170 may be generally oval as shown in FIGS. 11 and 49-54 with orifice 175 adapted to align with opening in foam contacting portion 200. Decoupling element 170 may absorb some of the forces from the frame, headgear and tube by flexing and compressing (e.g., like a gusset or suspension system) so as to prevent misalignment of the foam contacting portion 200 with the nares of the patient. Decoupling element 170 may be formed from a flexible material such as silicone. Decoupling element 170 may be connected to frame 110 by an interference fit. Alternatively, decoupling element 170 may be permanently fixed or formed with the frame 110 by co-molding or glue. Decoupling element 170 may also be attached to the foam contacting portion. In one form, the foam contacting portion 200 is a layer of foam that is wrapped, connected, slid or otherwise positioned on a supporting structure.

In a further embodiment, the decoupling element 170 of the support structure may be the decoupling element disclosed in U.S. patent application Ser. No. 12/219,852 (Guney), which is incorporated herein by reference in its entirety. In an embodiment, the frame 110 of the mask system 100 may be the frame disclosed in U.S. patent application Ser. No. 12/219,852 (Guney).

The particularly soft mechanical properties of an exemplary foam (as disclosed in PCT Publication No. WO 2008/070929 (Veliss et al)) means that the foam contacting portion may be provided with support and reinforcement to perform its function with the nasal air passages. The frame 110 and decoupling element 170 may be suitable structures to provide this supporting mechanism, providing appropriate balance between shape and support for positioning the foam contacting portion 200, structural compliance and resilience for comfort on the nose (e.g., allow rotational, axial, and/or lateral movement to resist tube drag and headgear tension).

2.4 Headgear

Headgear 50 may include three main strap sections: top straps 60, back strap 70 and side straps 80. Top straps 60 may be placed over the top of the patient's head and may be one continuous piece of material or multiple pieces of material joined together by a buckle 95 as shown in FIGS. 1-3.

Back strap 70 may be placed around the back of the patient's head and may be one piece of continuous material or multiple pieces of material joined together by a buckle.

Top strap 60 and back strap 70 may be adjusted using hook and loop fasteners (such as Velcro™) or with the buckle 95. Buckle 95 may also have a lock that prevents the top strap 60 from loosening off. Such a buckle 95 with lock is described in U.S. Pat. No. 7,318,437 (Gunaratnam et al), which is incorporate herein by reference in its entirety.

Side straps 80 are generally positioned on the sides of the patient's face, from above or near the ear, passing under the eyes and ending at the nose of the patient. Side straps 80 may be reinforced with rigidizers 90 that may assist in supporting the mask system 100 in position. Rigidizers 90 may be attached to side straps at: the patient contacting side of side straps 80 (not shown), within side straps 80 by co-molding or other such technique (not shown), or on the exterior non-patient contacting side of side straps 80 (see FIGS. 1 and 3). Rigidizers 90 may be connected to side straps 80 by: gluing, stitching, co-molding, or any other suitable means.

Side straps 80 may also include cheek supports 85 that lie generally horizontally on the cheeks of the patient, generally at the cheek bone region, to better position the mask system 100 on the face of the user. Such an arrangement is shown in U.S. patent application Ser. No. 12/219,852 (Guney).

3. Air Delivery

3.1 Introduction

The mask system 100 may be connected to a supply of pressurized breathable gas to deliver therapy to the patient. The air delivery system 130 may include: an elbow 140 and a tube 150 as shown in FIGS. 1-3.

3.2 Elbow

Elbow 140 is generally an L-shaped, hollow cylinder and may be constructed of a generally rigid material such as polycarbonate or polypropylene. Elbow 140 may also include one or more vent holes 160 (see FIG. 3) to allow exhaust gases from the patient to expel into the atmosphere. Elbow 140 may also include a one way anti-asphyxia valve.

In a further embodiment, the elbow 140 may be the same as that disclosed in U.S. patent application Ser. No. 12/219,852 (Guney).

3.3 Tube

Tube 150 is generally a hollow, cylinder with a reinforcing member 155 (see FIGS. 1 and 3) integrally molded into tube 150. The reinforcing member 155 may include a generally helical shape so as to allow the tube 150 to flex without occluding. Tube 150 may be flexible, resilient and stretchable in a longitudinal direction.

Tube 150 may be constructed of a polymer or fabric, e.g., Hytrel™. Such a tube is disclosed in U.S. Provisional Patent Application No. 61/031,407 (Henry et al), filed Feb. 26, 2008, which is incorporated herein by reference in its entirety.

Tube 150 may connect to the elbow 140 so as to deliver breathable gas to the patient through the patient interface 10. The tube 150 may connect to elbow 140 by any reasonable means, such as a clip, interference fit, etc.

In a further embodiment, the tube 150 may be the same as that disclosed in U.S. patent application Ser. No. 12/219,852 (Guney).

In the illustrated forms of the invention, the mask system 100 of which the foam interfacing portion forms a part is generally configured under the nose of the patient. However, in other forms, the mask system 100 may be a nasal or full-face mask, or an oro-nasal mask. For example, in one form, a foam-based under-the-nose configuration may be combined with a gel, silicone or rubber portion, for example a silicone mouth cushion.

While the invention has been described in connection with what are presently considered to be the most practical and preferred embodiments, it is to be understood that the invention is not to be limited to the disclosed embodiments, but on the contrary, is intended to cover various modifications and equivalent arrangements included within the spirit and scope of the invention. Also, the various embodiments described above may be implemented in conjunction with other embodiments, e.g., aspects of one embodiment may be combined with aspects of another embodiment to realize yet other embodiments. Further, each independent feature or component of any given assembly may constitute an additional embodiment. Furthermore, each individual component of any given assembly, one or more portions of an individual component of any given assembly, and various combinations of components from one or more embodiments may include one or more ornamental design features. In addition, while the invention has particular application to patients who suffer from OSA, it is to be appreciated that patients who suffer from other illnesses (e.g., congestive heart failure, diabetes, morbid obesity, stroke, bariatric surgery, etc.) can derive benefit from the above teachings. Moreover, the above teachings have applicability with patients and non-patients alike in non-medical applications.

Claims

1. A patient interface for delivering breathable gas to a patient, the patient interface comprising:

a foam interfacing portion formed of foam and adapted to provide a nasal interface, the foam interfacing portion including an orifice adapted to be in fluid communication with both the patient's nares in use; and
a positioning and stabilizing structure to support the foam interfacing portion in an operative position on the patient's face,
wherein the foam interfacing portion is removably connected to the positioning and stabilizing structure, the foam interfacing portion being wrapped around at least a portion of the positioning and stabilizing structure such that an exterior surface of a bottom underside portion of the foam interfacing portion forms a concave shape extending from a first side of the at least a portion of the positioning and stabilizing structure to a second side of the at least a portion of the positioning and stabilizing structure opposite the first side, the exterior surface of the bottom underside portion of the foam interfacing portion being in direct contact with the positioning and stabilizing structure, and
wherein the foam interfacing portion being secured in its wrapped position by one or more connectors.

2. A patient interface according to claim 1, wherein the positioning and stabilizing structure includes a frame, a decoupling element, and/or headgear.

3. A patient interface according to claim 2, wherein the positioning and stabilizing structure includes the decoupling element, and wherein the foam interfacing portion is provided to an exterior surface of the decoupling element.

4. A patient interface according to claim 2, wherein the positioning and stabilizing structure includes the frame and the decoupling element, and wherein the foam interfacing portion is wrapped around the frame and the decoupling element.

5. A patient interface according to claim 2, wherein the positioning and stabilizing structure includes the decoupling element, and wherein the decoupling element is formed from silicone.

6. A patient interface according to claim 2, wherein the foam interfacing portion is secured in position using existing structure on the decoupling element, frame, and/or headgear.

7. A patient interface according to claim 2, wherein the orifice is structured to align with an orifice provided to the frame and/or decoupling element.

8. A patient interface according to claim 2, wherein the positioning and stabilizing structure includes the frame, and wherein the foam interfacing portion covers substantially an entirety of the frame.

9. A patient interface according to claim 1, wherein the connectors include a male connector and a female connector.

10. A patient interface according to claim 9, wherein the foam interfacing portion includes the male connector and a frame and/or decoupling element includes the female connector.

11. A patient interface according to claim 1, wherein the exterior surface of the bottom underside portion of the foam interfacing portion has a first end at a first side of the foam interfacing portion and a second end at an opposite second side of the foam interfacing portion, and

wherein the entire exterior surface from the first end to the second end is formed into the concave shape.

12. A patient interface according to claim 11, wherein an exterior surface on a topside patient-contacting portion of the foam interfacing portion has a convex shape that matches a curvature of the concave shape of the exterior surface of the bottom underside portion of the foam interfacing portion.

13. A patient interface according to claim 12, wherein the convex shape of the exterior surface of the topside patient-contacting portion of the foam interfacing portion is configured and positioned to directly contact under the patient's nose in use.

14. A patient interface according to claim 12, wherein a distance between the exterior surface of the bottom underside portion of the foam interfacing portion and the exterior surface of the topside patient-contacting portion of the foam interfacing portion is uniform from the first side of the foam interfacing portion to the second side of the foam interfacing portion.

15. A patient interface according to claim 1, wherein the connectors include a hook and loop arrangement.

16. A patient interface according to claim 1, wherein the connectors include a press stud arrangement.

17. A patient interface according to claim 1, wherein the connectors include a hook and loop material.

18. A patient interface according to claim 1, wherein the connectors include a clip arrangement.

19. A patient interface according to claim 1, wherein the orifice of the foam interfacing portion is D-shaped.

20. A patient interface according to claim 1, wherein the orifice of the foam interfacing portion includes a width of about 15-50 mm.

21. A patient interface according to claim 1, wherein the orifice of the foam interfacing portion includes a height of about 5-30 mm.

22. A patient interface according to claim 1, wherein the foam interfacing portion includes a thickness of about 0.5-50 mm.

23. A patient interface according to claim 1, wherein the foam interfacing portion includes a length of about 10-200 mm and a width of about 10-100 mm.

24. A patient interface according to claim 1, wherein the foam interfacing portion is structured to form a seal with the patient's nares.

25. A patient interface according to claim 1, wherein the exterior surface of the bottom underside portion of the foam interfacing portion substantially surrounds the at least a portion of the positioning and stabilizing structure.

26. A patient interface according to claim 1, wherein the positioning and stabilizing structure is flexible, compressible and/or movable to allow rotational, axial, and/or lateral movement of the foam interfacing portion.

27. A patient interface according to claim 1, wherein at least one of the one or more connectors is disposed on the exterior surface of the bottom underside portion of the foam interfacing portion.

28. A patient interface according to claim 1, wherein the concave shape substantially conforms to a shape of the at least a portion of the positioning and stabilizing structure.

29. A patient interface according to claim 1, wherein the foam is configured and positioned to directly contact under and around the patient's nose in use.

30. A patient interface according to claim 1, wherein the positioning and stabilizing structure includes a frame, and

wherein the positioning and stabilizing structure resists the application of tube drag and/or headgear tension to the foam interfacing portion.

31. A patient interface according to claim 1, wherein the foam interfacing portion is wrapped around the positioning and stabilizing structure such that an underside surface of the foam interfacing portion forms an arc shape around the at least a portion of the positioning and stabilizing structure.

32. A patient interface according to claim 1, wherein an entire underside surface of the foam interfacing portion is in contact with the positioning and stabilizing structure.

33. A patient interface according to claim 1, wherein the foam interfacing portion forms an inverted U-shape and the foam interfacing portion covers the at least a portion of the positioning and stabilizing structure.

34. A patient interface according to claim 1, wherein at least one of the one or more connectors is disposed on the exterior surface of the bottom underside portion of the foam interfacing portion, and

wherein the concave shape substantially conforms to a shape of the at least a portion of the positioning and stabilizing structure.

35. A patient interface according to claim 1, wherein the foam interfacing portion is wrapped around the positioning and stabilizing structure such that an underside surface of the foam interfacing portion forms an arc shape around the at least a portion of the positioning and stabilizing structure,

wherein an entire underside surface of the foam interfacing portion is in contact with the positioning and stabilizing structure,
wherein the exterior surface of the bottom underside portion of the foam interfacing portion has a first end at a first side of the foam interfacing portion and a second end at an opposite second side of the foam interfacing portion, the entire exterior surface from the first end to the second end being formed into the concave shape,
wherein an exterior surface on a topside patient-contacting portion of the foam interfacing portion has a convex shape that matches a curvature of the concave shape of the exterior surface of the bottom underside portion of the foam interfacing portion,
wherein the convex shape of the exterior surface of the topside patient-contacting portion of the foam interfacing portion is configured and positioned to directly contact under the patient's nose in use,
wherein a distance between the exterior surface of the bottom underside portion of the foam interfacing portion and the exterior surface of the topside patient-contacting portion of the foam interfacing portion is uniform from the first side of the foam interfacing portion to the second side of the foam interfacing portion,
wherein the foam interfacing portion forms an inverted U-shape and the foam interfacing portion covers the at least a portion of the positioning and stabilizing structure,
wherein at least one of the one or more connectors is disposed on the exterior surface of the bottom underside portion of the foam interfacing portion, and
wherein the concave shape substantially conforms to a shape of the at least a portion of the positioning and stabilizing structure.
Referenced Cited
U.S. Patent Documents
443191 December 1890 Illing
781516 January 1905 Guthrie, Jr.
1081745 December 1913 Johnston
1125542 January 1915 Humphries
1192186 July 1916 Greene
1229050 June 1917 Donald
1282527 October 1918 Bidonde
1362766 December 1920 McGargill
1445010 February 1923 Feinberg
1610793 December 1926 Kaufman
1873160 August 1932 Sturtevant
2353643 July 1944 Bulbulian
2415846 February 1947 Randall
2433565 December 1947 Korman
2625155 January 1953 Engelder
2706983 April 1955 Matheson et al.
2931356 April 1960 Schwarz
3013556 December 1961 Galleher
3670726 March 1972 Mahon et al.
3682171 August 1972 Dali et al.
3739774 June 1973 Gregory
3754552 August 1973 King
3827433 August 1974 Shannon
3861385 January 1975 Carden
3902486 September 1975 Guichard
3905361 September 1975 Hewson et al.
3938614 February 17, 1976 Ahs
3972321 August 3, 1976 Proctor
4006744 February 8, 1977 Steer
4142527 March 6, 1979 Garcia
4153051 May 8, 1979 Shippert
4156426 May 29, 1979 Gold
4248218 February 3, 1981 Fischer
4263908 April 28, 1981 Mizerak
4264743 April 28, 1981 Maruyama et al.
4267845 May 19, 1981 Robertson, Jr. et al.
4273124 June 16, 1981 Zimmerman
4312359 January 26, 1982 Olson
4367735 January 11, 1983 Dali
4367816 January 11, 1983 Wilkes
4406283 September 27, 1983 Bir
4414973 November 15, 1983 Matheson et al.
4422456 December 27, 1983 Teip
4449526 May 22, 1984 Elam
4455675 June 19, 1984 Bose et al.
4493614 January 15, 1985 Chu et al.
4548200 October 22, 1985 Wapner
4549542 October 29, 1985 Chein
4572323 February 25, 1986 Randall
4587967 May 13, 1986 Chu et al.
4601465 July 22, 1986 Roy
4617637 October 14, 1986 Chu et al.
4630604 December 23, 1986 Montesi
4641647 February 10, 1987 Behan
4660555 April 28, 1987 Payton
4671271 June 9, 1987 Bishop et al.
4676241 June 30, 1987 Webb et al.
4699139 October 13, 1987 Marshall et al.
4706664 November 17, 1987 Snook et al.
4711636 December 8, 1987 Bierman
4713844 December 22, 1987 Westgate
4753233 June 28, 1988 Grimes
4767411 August 30, 1988 Edmunds
4774946 October 4, 1988 Ackerman et al.
4782832 November 8, 1988 Trimble et al.
4790829 December 13, 1988 Bowden et al.
4802857 February 7, 1989 Laughlin
4803981 February 14, 1989 Vickery
4811730 March 14, 1989 Milano
4830138 May 16, 1989 Palmaer et al.
4838878 June 13, 1989 Kalt et al.
4899740 February 13, 1990 Napolitano
4907584 March 13, 1990 McGinnis
4915105 April 10, 1990 Lee
4919128 April 24, 1990 Kopala et al.
4919654 April 24, 1990 Kalt
4944310 July 31, 1990 Sullivan
4945907 August 7, 1990 Tayebi
4960121 October 2, 1990 Nelson et al.
4966590 October 30, 1990 Kalt
4969880 November 13, 1990 Zamierowski
4971051 November 20, 1990 Toffolon
4976698 December 11, 1990 Stokley
4989599 February 5, 1991 Carter
4996983 March 5, 1991 Amrhein
5000173 March 19, 1991 Zalkin et al.
5005571 April 9, 1991 Dietz
5020163 June 4, 1991 Aileo et al.
5022900 June 11, 1991 Bar-Yona et al.
5023955 June 18, 1991 Murphy, II et al.
5025805 June 25, 1991 Nutter
5038772 August 13, 1991 Kolbe et al.
5042478 August 27, 1991 Kopala et al.
5046491 September 10, 1991 Derrick
5074297 December 24, 1991 Venegas
5113857 May 19, 1992 Dickerman et al.
5117818 June 2, 1992 Palfy
5121745 June 16, 1992 Israel
5127397 July 7, 1992 Kohnke
5137017 August 11, 1992 Salter
5138722 August 18, 1992 Urella et al.
D333015 February 2, 1993 Farmer et al.
5188101 February 23, 1993 Tumolo
5207665 May 4, 1993 Davis et al.
5220699 June 22, 1993 Farris
5243709 September 14, 1993 Sheehan et al.
5243971 September 14, 1993 Sullivan et al.
5245995 September 21, 1993 Sullivan et al.
5261893 November 16, 1993 Zamierowski
5263939 November 23, 1993 Wortrich
5265592 November 30, 1993 Beaussant
5265595 November 30, 1993 Rudolph
5267557 December 7, 1993 Her-Mou
5269296 December 14, 1993 Landis
5271391 December 21, 1993 Graves
5304146 April 19, 1994 Johnson et al.
5299599 April 5, 1994 Farmer et al.
5335656 August 9, 1994 Bowe et al.
5349949 September 27, 1994 Schegerin
5355878 October 18, 1994 Griffiths et al.
5355893 October 18, 1994 Mick et al.
5364367 November 15, 1994 Banks et al.
5372130 December 13, 1994 Stem et al.
5372388 December 13, 1994 Gargiulo
5372389 December 13, 1994 Tam et al.
5372390 December 13, 1994 Conway et al.
5372391 December 13, 1994 Bast et al.
5375593 December 27, 1994 Press
5385141 January 31, 1995 Granatiero
5394568 March 7, 1995 Brostrom et al.
5396885 March 14, 1995 Nelson
5398676 March 21, 1995 Press et al.
5400776 March 28, 1995 Bartholomew
5419318 May 30, 1995 Tayebi
5425359 June 20, 1995 Liou
5429683 July 4, 1995 Le Mitouard
5437267 August 1, 1995 Weinstein et al.
5441046 August 15, 1995 Starr et al.
5462528 October 31, 1995 Roewer
5477852 December 26, 1995 Landis et al.
5488948 February 6, 1996 Dubruille et al.
5509409 April 23, 1996 Weatherholt
5513634 May 7, 1996 Jackson
5513635 May 7, 1996 Bedi
5526806 June 18, 1996 Sansoni
5533506 July 9, 1996 Wood
5538000 July 23, 1996 Rudolph
5538001 July 23, 1996 Bridges
5540223 July 30, 1996 Starr et al.
5560354 October 1, 1996 Berthon-Jones et al.
5570684 November 5, 1996 Behr
5592938 January 14, 1997 Scarberry et al.
5623923 April 29, 1997 Bertheau et al.
5647357 July 15, 1997 Barnett et al.
5653228 August 5, 1997 Byrd
5655527 August 12, 1997 Scarberry et al.
5662101 September 2, 1997 Ogden et al.
5682881 November 4, 1997 Winthrop et al.
D293613 January 5, 1988 Wingler
5704345 January 6, 1998 Berthon-Jones et al.
5707342 January 13, 1998 Tanaka
5724965 March 10, 1998 Handke et al.
5735272 April 7, 1998 Dillon et al.
5740799 April 21, 1998 Nielson
5752511 May 19, 1998 Simmons et al.
5794619 August 18, 1998 Edeiman et al.
5807341 September 15, 1998 Heim
5842469 December 1, 1998 Rapp et al.
5906203 May 25, 1999 Klockseth et al.
5918598 July 6, 1999 Belfer et al.
5921239 July 13, 1999 McCall
5954049 September 21, 1999 Foley et al.
5975079 November 2, 1999 Hellings et al.
6012455 January 11, 2000 Goldstein
6019101 February 1, 2000 Cotner et al.
6026811 February 22, 2000 Settle
6044844 April 4, 2000 Kwok et al.
6082360 July 4, 2000 Rudolph et al.
6086118 July 11, 2000 McNaughton et al.
6095996 August 1, 2000 Steer et al.
6098205 August 8, 2000 Schwartz et al.
6109263 August 29, 2000 Feuchtgruber
6112746 September 5, 2000 Kwok et al.
6119693 September 19, 2000 Kwok et al.
6119694 September 19, 2000 Correa
6123071 September 26, 2000 Berthon-Jones et al.
6123082 September 26, 2000 Berthon-Jones
6139787 October 31, 2000 Harrison
6152137 November 28, 2000 Schwartz et al.
6193914 February 27, 2001 Harrison
6196223 March 6, 2001 Belfer et al.
6211263 April 3, 2001 Cinelli et al.
6231548 May 15, 2001 Bassett
6241930 June 5, 2001 Harrison
6258066 July 10, 2001 Urich
6295366 September 25, 2001 Haller et al.
6328038 December 11, 2001 Kessler et al.
6338340 January 15, 2002 Finch et al.
6341606 January 29, 2002 Bordewick et al.
6347631 February 19, 2002 Hansen et al.
6357441 March 19, 2002 Kwok et al.
6358279 March 19, 2002 Tahi et al.
6374826 April 23, 2002 Gunaratnam et al.
6412487 July 2, 2002 Gunaratnam
6412488 July 2, 2002 Barnett et al.
6412593 July 2, 2002 Jones
6412847 July 2, 2002 De Gaillard
6419660 July 16, 2002 Russo
6422238 July 23, 2002 Lithgow
6423036 July 23, 2002 Van Huizen
6431172 August 13, 2002 Bordewick
6434796 August 20, 2002 Speirs
6439234 August 27, 2002 Curti et al.
6448303 September 10, 2002 Paul
6467482 October 22, 2002 Boussignac
6467483 October 22, 2002 Kopacko
6470887 October 29, 2002 Martinez
6478026 November 12, 2002 Wood
6482178 November 19, 2002 Andrews et al.
6491034 December 10, 2002 Gunaratnam et al.
6513526 February 4, 2003 Kwok et al.
6530373 March 11, 2003 Patron et al.
6532961 March 18, 2003 Kwok et al.
6536435 March 25, 2003 Fecteau et al.
6561188 May 13, 2003 Ellis
6561190 May 13, 2003 Kwok et al.
6561192 May 13, 2003 Palmer
6561193 May 13, 2003 Noble
6571798 June 3, 2003 Thornton
6579267 June 17, 2003 Lynch et al.
6581601 June 24, 2003 Ziaee
6581602 June 24, 2003 Kwok et al.
6584975 July 1, 2003 Taylor
6595214 July 22, 2003 Hecker et al.
6595215 July 22, 2003 Wood
6607516 August 19, 2003 Cinelli et al.
6627289 September 30, 2003 Dilnik et al.
6631718 October 14, 2003 Lovell
6634358 October 21, 2003 Kwok et al.
6637434 October 28, 2003 Noble
6644315 November 11, 2003 Ziaee
6655385 December 2, 2003 Curti et al.
6663600 December 16, 2003 Bierman et al.
6669712 December 30, 2003 Cardoso
D485905 January 27, 2004 Moore et al.
6679257 January 20, 2004 Robertson et al.
6679265 January 20, 2004 Strickland et al.
6701927 March 9, 2004 Kwok et al.
6710099 March 23, 2004 Cinelli et al.
6766800 July 27, 2004 Chu et al.
6766817 July 27, 2004 da Silva
6776162 August 17, 2004 Wood
6776163 August 17, 2004 Dougill et al.
6789543 September 14, 2004 Cannon
6805117 October 19, 2004 Ho et al.
6807967 October 26, 2004 Wood
6817362 November 16, 2004 Gelinas
6820617 November 23, 2004 Robertson et al.
6823865 November 30, 2004 Drew et al.
6823869 November 30, 2004 Raje et al.
6826783 December 7, 2004 Grove et al.
6834650 December 28, 2004 Fini
6860270 March 1, 2005 Sniadach
6895965 May 24, 2005 Scarberry et al.
6907882 June 21, 2005 Ging et al.
6918404 July 19, 2005 Dias da Silva
6926004 August 9, 2005 Schumacher
6938620 September 6, 2005 Payne, Jr.
6968844 November 29, 2005 Liland
6972003 December 6, 2005 Bierman et al.
6986352 January 17, 2006 Frater et al.
6997177 February 14, 2006 Wood
7011090 March 14, 2006 Drew et al.
7018362 March 28, 2006 Bierman et al.
7052127 May 30, 2006 Harrison
7066586 June 27, 2006 da Silva
7076282 July 11, 2006 Munro et al.
7080645 July 25, 2006 Genger et al.
7101359 September 5, 2006 Kline et al.
7107989 September 19, 2006 Frater et al.
7146976 December 12, 2006 McKown
7152599 December 26, 2006 Thomas
7152601 December 26, 2006 Barakat et al.
7178525 February 20, 2007 Matula et al.
7191781 March 20, 2007 Wood
7207328 April 24, 2007 Altemus
7210481 May 1, 2007 Lovell et al.
7237551 July 3, 2007 Ho et al.
7243723 July 17, 2007 Surjaatmadja
D550836 September 11, 2007 Chandran et al.
D552733 October 9, 2007 Criscuolo et al.
7285255 October 23, 2007 Kadlec et al.
7302950 December 4, 2007 Berthon-Jones et al.
7318437 January 15, 2008 Gunaratnam et al.
7331348 February 19, 2008 Beevers
7523754 April 28, 2009 Lithgow
7658189 February 9, 2010 Davidson
20010020474 September 13, 2001 Hecker et al.
20020005198 January 17, 2002 Kwok et al.
20020029780 March 14, 2002 Frater et al.
20020046755 April 25, 2002 DeVoss
20020053347 May 9, 2002 Ziaee
20020066452 June 6, 2002 Kessler et al.
20020069872 June 13, 2002 Gradon et al.
20020096178 July 25, 2002 Ziaee
20020124849 September 12, 2002 Billette De Villemeur
20020143296 October 3, 2002 Russo
20020157673 October 31, 2002 Kessler et al.
20020174868 November 28, 2002 Kwok et al.
20020185134 December 12, 2002 Bishop
20030000526 January 2, 2003 Goebel
20030019495 January 30, 2003 Palkon et al.
20030019496 January 30, 2003 Kopacko et al.
20030079749 May 1, 2003 Strickland et al.
20030089373 May 15, 2003 Gradon et al.
20030111080 June 19, 2003 Olsen et al.
20030154980 August 21, 2003 Berthon-Jones et al.
20030168063 September 11, 2003 Gambone et al.
20030196656 October 23, 2003 Moore et al.
20030196658 October 23, 2003 Ging et al.
20040025882 February 12, 2004 Madaus et al.
20040025885 February 12, 2004 Payne, Jr.
20040045551 March 11, 2004 Eaton et al.
20040065328 April 8, 2004 Amarasinghe et al.
20040106891 June 3, 2004 Langan et al.
20040107968 June 10, 2004 Griffiths
20040111104 June 10, 2004 Schein et al.
20040112384 June 17, 2004 Lithgow et al.
20040118406 June 24, 2004 Lithgow et al.
20040127856 July 1, 2004 Johnson
20040211428 October 28, 2004 Jones
20040226564 November 18, 2004 Persson
20040226566 November 18, 2004 Gunaratnam et al.
20050011523 January 20, 2005 Aylsworth et al.
20050028822 February 10, 2005 Sleeper et al.
20050033247 February 10, 2005 Thompson
20050039757 February 24, 2005 Wood
20050051171 March 10, 2005 Booth
20050051176 March 10, 2005 Riggins
20050056286 March 17, 2005 Huddart et al.
20050061326 March 24, 2005 Payne, Jr.
20050066976 March 31, 2005 Wondka
20050101933 May 12, 2005 Marrs et al.
20050150495 July 14, 2005 Rittner et al.
20050155604 July 21, 2005 Ging et al.
20050211252 September 29, 2005 Lang et al.
20050241644 November 3, 2005 Lynch et al.
20050284481 December 29, 2005 Meyer
20060060200 March 23, 2006 Ho et al.
20060081250 April 20, 2006 Bordewick et al.
20060095008 May 4, 2006 Lampropoulos et al.
20060095009 May 4, 2006 Lampropoulos et al.
20060118117 June 8, 2006 Berthon-Jones
20060124131 June 15, 2006 Chandran et al.
20060137690 June 29, 2006 Gunaratnam et al.
20060174887 August 10, 2006 Chandran et al.
20060020514 January 26, 2006 Jones et al.
20060201514 September 14, 2006 Jones
20060207597 September 21, 2006 Wright
20060237017 October 26, 2006 Davidson et al.
20060283461 December 21, 2006 Lubke et al.
20070023044 February 1, 2007 Kwok et al.
20070125387 June 7, 2007 Zollinger et al.
20070144525 June 28, 2007 Davidson et al.
20070186930 August 16, 2007 Davidson et al.
20070267017 November 22, 2007 McAuley et al.
20070272249 November 29, 2007 Chandran et al.
20070282272 December 6, 2007 Bannon et al.
20080004573 January 3, 2008 Kaufmann et al.
20080006277 January 10, 2008 Worboys et al.
20080047560 February 28, 2008 Veliss et al.
20080060649 March 13, 2008 Veliss et al.
20080065022 March 13, 2008 Kyvik et al.
20080110469 May 15, 2008 Weinberg
20080200880 August 21, 2008 Kyvik et al.
20080257354 October 23, 2008 Davidson et al.
20090044808 February 19, 2009 Guney et al.
20100000534 January 7, 2010 Kooij et al.
20100018534 January 28, 2010 Veliss et al.
20110000492 January 6, 2011 Veliss et al.
Foreign Patent Documents
199651130 October 1996 AU
2005100738 November 2005 AU
185017 May 1907 DE
30 11 900 October 1980 DE
146 688 February 1981 DE
37 19 009 December 1988 DE
39 27 038 February 1991 DE
297 23 101 July 1998 DE
197 03 526 August 1998 DE
199 44 242 March 2001 DE
10002571 July 2001 DE
102 13 905 October 2002 DE
10 2004 055 433 November 2004 DE
0 288 937 November 1988 EP
0 427 474 May 1991 EP
0 466 960 January 1992 EP
0 303 090 April 1992 EP
0 658 356 June 1995 EP
0 776 679 June 1997 EP
1 099 452 May 2001 EP
1 258 266 November 2002 EP
1 293 227 March 2003 EP
1 481 702 December 2004 EP
2 720 280 December 1995 FR
532214 January 1941 GB
2 176 404 December 1986 GB
2 368 533 May 2002 GB
2 385 533 August 2003 GB
2000-515784 November 2000 JP
WO 1982/003548 October 1982 WO
WO 1987/001950 April 1987 WO
WO 1992/020392 November 1992 WO
WO 1992/020395 November 1992 WO
WO 1996/028207 September 1996 WO
WO 1998/004310 February 1998 WO
WO 1998/012965 April 1998 WO
WO 1998/023305 June 1998 WO
WO 1999/016327 April 1999 WO
WO 1999/025410 May 1999 WO
WO 1999/043375 September 1999 WO
WO 1999/061088 December 1999 WO
WO 2000/020072 April 2000 WO
WO 2000/038772 July 2000 WO
WO 2000/050121 August 2000 WO
WO 00/69521 November 2000 WO
WO 2000/072905 December 2000 WO
WO 2000/074758 December 2000 WO
WO 2000/076568 December 2000 WO
WO 2000/078384 December 2000 WO
WO 2001/062326 August 2001 WO
WO 2001/095965 December 2001 WO
WO 2001/097892 December 2001 WO
WO 2001/097893 December 2001 WO
WO 2002/038221 May 2002 WO
WO 2002/045784 June 2002 WO
WO 2003/090827 November 2003 WO
WO 2003/105921 December 2003 WO
WO 2004/022146 March 2004 WO
WO 2004/041342 May 2004 WO
WO 2004/078230 September 2004 WO
WO 2005/053781 June 2005 WO
WO 2005/063328 July 2005 WO
WO 2005/086943 September 2005 WO
WO 2005/099801 October 2005 WO
WO 2005/110220 November 2005 WO
WO 2005/118040 December 2005 WO
PCT/AU2006/000031 January 2006 WO
PCT/AU2006/000417 March 2006 WO
PCT/AU2006/000770 June 2006 WO
WO 2006/069415 July 2006 WO
WO 2006/074513 July 2006 WO
WO 2006/074516 July 2006 WO
WO 2006/099658 September 2006 WO
WO 2006/130903 December 2006 WO
WO 2007/009182 January 2007 WO
WO 2007/016424 February 2007 WO
WO 2007/041751 April 2007 WO
WO 2007/041786 April 2007 WO
WO 2007/048174 May 2007 WO
WO 2007/053878 May 2007 WO
PCT/AU2007/001936 December 2007 WO
WO 2007/143772 December 2007 WO
WO 2007/145534 December 2007 WO
WO 2008/070929 December 2007 WO
WO 2008/011682 January 2008 WO
WO 2008/011683 January 2008 WO
WO 2008/040050 April 2008 WO
WO 2004/073778 June 2008 WO
WO 2009/108994 September 2009 WO
WO 2009/109004 September 2009 WO
WO 2010/028425 March 2010 WO
Other references
  • U.S. Appl. No. 10/385,701, filed Aug. 2003, Berthon-Jones et al.
  • U.S. Appl. No. 10/533,928, filed Jul. 2005, Berthon-Jones.
  • U.S. Appl. No. 10/584,711, filed Dec. 2004, Davidson.
  • U.S. Appl. No. 10/655,622, filed Sep. 2003, Lithgow.
  • U.S. Appl. No. 10/781,929, filed Jan. 2008, Gunaratnam et al.
  • U.S. Appl. No. 10/871,929, filed Feb. 2004, Surjaatmadja.
  • U.S. Appl. No. 11/080,446, filed Jul. 2005, Ging et al.
  • U.S. Appl. No. 11/447,295, filed Jun. 2006, Lubke et al.
  • U.S. Appl. No. 11/474,415, filed Jun. 2006, Davidson et al.
  • U.S. Appl. No. 11/491,016, filed Feb. 2007, Kwok et al.
  • U.S. Appl. No. 11/703,082, filed Feb. 2007, Davidson.
  • U.S. Appl. No. 11/878,932, filed Jul. 2007, Veliss et al.
  • U.S. Appl. No. 11/878,933, filed Jul. 2007, Veliss et al.
  • U.S. Appl. No. 12/081,696, filed Apr. 2008, Davidson et al.
  • U.S. Appl. No. 12/085,191, filed May 2008, Kwok et al.
  • U.S. Appl. No. 12/219,852, filed Jan. 2008 ,Guney et al.
  • U.S. Appl. No. 12/309,696, filed Jan. 2009, Kwok et al.
  • U.S. Appl. No. 12/382,517, filed Mar. 2009, Lithgow.
  • U.S. Appl. No. 12/448,250, filed Jun. 2009, Veliss et al.
  • U.S. Appl. No. 12/461,448, filed Aug. 2009, Berthon-Jones.
  • U.S. Appl. No. 12/478,537, filed Jun. 2009, Kooij et al.
  • U.S. Appl. No. 12/656,466, filed Jan. 2010, Biener et al.
  • U.S. Appl. No. 12/700,878, filed Feb. 2010, Davidson et al.
  • U.S. Appl. No. 60/424,686, filed Nov. 2002, Lithgow.
  • U.S. Appl. No. 60/483,622, filed Jul. 2003, Kwok et al.
  • U.S. Appl. No. 60/533,214, filed Dec. 2003, Drew.
  • U.S. Appl. No. 60/634,802, filed Dec. 2004, Chandran.
  • U.S. Appl. No. 60/645,672, filed Jan. 2005, Chandran.
  • U.S. Appl. No. 60/795,615, filed Apr. 2006, Judson et al.
  • U.S. Appl. No. 60/833,841, filed Jul. 2006, Veliss.
  • U.S. Appl. No. 60/835,442, filed Aug. 2006, Selvarajan et al.
  • U.S. Appl. No. 60/852,649, filed Oct. 2006, Selvarajan et al.
  • U.S. Appl. No. 60/874,968, filed Dec. 2006, Kwok et al.
  • U.S. Appl. No. 60/907,856, filed Apr. 2007, Davidson et al.
  • U.S. Appl. No. 60/924,241, filed May 2007, Kwok et al.
  • U.S. Appl. No. 60/929,393, filed Jun. 2007, Kwok et al.
  • U.S. Appl. No. 60/935,179, filed Jul. 2007, Guney et al.
  • U.S. Appl. No. 60/935,336, filed Aug. 2007, Davidson et al.
  • U.S. Appl. No. 60/996,160, filed Nov. 2007, Guney et al.
  • U.S. Appl. No. 61/006,409, filed Jan. 2008, Guney et al.
  • U.S. Appl. No. 61/031,407, filed Feb. 2008, Henry et al.
  • U.S. Appl. No. 61/064,818, filed Mar. 2008, Guney et al.
  • U.S. Appl. No. 61/071,512, filed May 2008, Guney et al.
  • U.S. Appl. No. 61/213,326, filed May 2009, Dravitzki et al.
  • U.S. Appl. No. 61/222,711, filed Jul. 2009, Dravitzki et al.
  • U.S. Appl. No. 61/263,175, filed Nov. 2009, Dravitzki et al.
  • U.S. Appl. No. 61/272,162, filed Aug. 2009, Dravitzki et al.
  • U.S. Appl. No. 61/272,250, filed Sep. 2009, Dravitzki et al.
  • International Preliminary Report on Patentability issued in PCT/AU2009/000240 (dated Sep. 7, 2010).
  • Supplementary European Search Report dated Dec. 18, 2009 in European Application No. 03810331.3.
  • International Search Report issued in Appln. No. PCT/AU2009/000240 (dated May 21, 2009).
  • “Ear Loop Face Mask”.
  • Adam J. Singer MD et al. “The Cyanoacrylate Topical Skin Adhesives,” American Journal of Emergency Medicine, vol. 26, 2008, pp. 490-496.
  • Webster's Third New International Dictionary, 1993, Dictionary definition for adjustable, bendable, and mild steel.
  • ComfortLite™, Respironics, http://comfortlite.respironics.com.
  • ComfortLite™ 2, Respironics, http://comfortlite2.respironics.com.
  • “If You Hate CPAP! You Need CPAP Pro®,” www.cpappro.com.
  • Webster's New World Dictionary, Third College Edition 1988, definition for engaged and flexible.
  • EP Supplementary Search Report issued in EP Application 03793493, dated Dec. 2, 2009.
  • European Search Report filed on Jul. 27, 2009 in EP Application No. 07784697.0.
  • European Search Report issued in EP 07845378.4, dated Dec. 1, 2009.
  • Examination Report filed in New Zealand Application 539836, dated Aug. 25, 2005.
  • Examiner's Report No. 3 dated Nov. 18, 2009 in New Zealand Application No. 2003275762.
  • Extended European Search Report dated Mar. 19, 2009 in European Application No. EP 08161249.
  • Extended European Search Report dated Sep. 3, 2009 in corresponding EP Application No. 09161984.1.
  • Extended European Search Report. Application No. EP 08154854, dated Nov. 27, 2008.
  • Fisher and Paykel Col.—Product Family—http://www.fphcare.com/osa/products.asp/.
  • Hans Rudolph, Inc.—Mask Products—http://www.rudolphkc.com/products.php?category=MASKS.
  • International Preliminary Report on Patentability for PCT/AU2004/001832, dated Jul. 3, 2006.
  • International Search Report filed in PCT/AU2005/000803, dated Jun. 30, 2005.
  • International Search Report filed in PCT/AU2006/000770, dated Aug. 3, 2006.
  • International Search Report for PCT/AU2007/001052, dated Oct. 9, 2007.
  • International Search Report for PCT/AU2007/001051, dated Nov. 5, 2007.
  • International Search Report for PCT/AU2004/001832, dated Mar. 24, 2005.
  • International Search Report for PCT/AU2007/001936, dated Mar. 4, 2008.
  • Joel W. Beam, “Tissue Adhesives for Simple Traumatic Lacerations,” Journal of Athletic Training, 2008, vol. 43, No. 2, pp. 222-224.
  • Merriam-Webster Online Dictionary definition of moveable from the 14th century.
  • Office Action dated Dec. 22, 2009 in European Appln. No. 04802133.1.
  • Office Action issued in Japanese Application No. 2007-513621 (dated Aug. 24, 2010) with English translation.
  • ResMed Co.—Mask Products—http://resmed.com/portal/site/ResMedUS/index.jsp?.
  • Respironics Co.—Mask Family—http://masksfamily.respironics.com/.
  • Snapp Nasal Interface, Tiara Medical Systems, Inc.—http://www.tiaramed.com/asp_shops/shopdisplayproducts.asp?id=109&cat=SNAPP%2A+Nasal+Interface.
  • Subbu Venkatraman et al., “Review Skin Adhesives and Skin Adhesion 1. Transdermal Drug Delivery Systems,” Biomaterials, vol. 19, 1998, pp. 1119-1136.
  • Supplementary European Search Report dated Sep. 8, 2009 in European Appln. No. 04802133.1.
  • Unsolicited email from Elson Silva, PhD, dated Mar. 28, 2008, “Requesting IDS of U.S. Pat. No. 6,766,817 for patents on fluids moving on porosity by Unsaturated Hydraulic Flow,” (email provided in both HTML and plain text format).
  • International Search Report PCT/AU2003/001163, dated Nov. 4, 2003.
  • International Search Report PCT/AU2003/001471, dated Feb. 12, 2004.
  • International Search Report PCT/AU2009/000240, dated May 21, 2009.
  • International Search Report PCT/AU2009/000262, dated Jun. 9, 2009.
  • International Search Report PCT/AU2009/001144, dated Dec. 18, 2009.
  • Office Action issued in European Appln. No. 05746824.1 (dated Mar. 22, 2011).
  • A Communication pursuant to Article 94(3) EPC dated Apr. 4, 2017, in a corresponding EP Application No. 09 716 773.8 (9 pages).
  • A Communication Pursuant to Article 94(3) EPC dated Jun. 4, 2018, in a corresponding European Patent Application No. EP 09 716 773.8 (10 pages).
Patent History
Patent number: 11129953
Type: Grant
Filed: Jun 28, 2018
Date of Patent: Sep 28, 2021
Patent Publication Number: 20180304037
Assignee: ResMed Pty Ltd (Bella Vista)
Inventors: Lee James Veliss (Rotterdam), Alicia Kristianne Wells (Sydney), Fiona Catherine Carroll (Hawkesbury), Gerard Michael Rummery (Woodford), David Anthony Pidcock (Sydney)
Primary Examiner: Jan Christopher L Merene
Assistant Examiner: Ned T Heffner
Application Number: 16/022,180
Classifications
Current U.S. Class: Including Means Inserted In Nasal Passage (128/206.11)
International Classification: A61M 16/06 (20060101);